BA
CHTP

BlackRock Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

BlackRock Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-54,875
Closed -$303K – 3765
2014
Q1 		$303K Buy
54,875
+2,598
+5% +$13K ﹤0.01% 2396
2013
Q4 		$232K Buy
52,277
+9,372
+22% +$31.7K ﹤0.01% 2567
2013
Q3 		$128K Buy
42,905
+2,832
+7% +$8.13K ﹤0.01% 2811
2013
Q2 		$92K Buy
+40,073
New +$81K ﹤0.01% 2952

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BlackRock Advisors's CHTP Position: Q2 2014 in Review

BlackRock Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 54,875 shares — an estimated $303K sold.

BlackRock Advisors first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $303K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • BlackRock Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • BlackRock Advisors sold 54,875 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $303K.
  • BlackRock Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • BlackRock Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $303K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.